Jan-eric Österlund

Biography

an-Eric has been heavily involved in private equity and management buy-outs during the last thirty years, concentrating on life science companies. He has been director or chairman of companies quoted on the stock exchanges in USA, Canada, Switzerland and Sweden and in numerous private companies. He engineered the buy-out of HemoCue from Pharmacia, was its chairman for four years and later sold it to a US medical group. He has been chairman of Investment AB Skrinet and Munksjö and a director of Ermitage Ltd, a fund management group based in London. He is at present chairman of MVI Equity, a private equity group and is a director of MVI Fund. Position: Chairman of the board Elected: 2012 Year of birth: 1945 Holdings*: 625 000 Independent in relation to the company and its management: No Independent in relation to larger shareholders: Yes

Research Interest

He has been director or chairman of companies quoted on the stock exchanges in USA, Canada, Switzerland and Sweden and in numerous private companies. He engineered the buy-out of HemoCue from Pharmacia, was its chairman for four years and later sold it to a US medical group. He has been chairman of Investment AB Skrinet and Munksjö and a director of Ermitage Ltd, a fund management group based in London. He is at present chairman of MVI Equity, a private equity group and is a director of MVI Fund.